Compare IONQ Inc (IONQ) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IONQ Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? IONQ Inc trades at $30.83 (market cap $12.73B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: IONQ Inc is far larger — about 2.5× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IONQ Inc for 34 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| IONQ | ORKA | |
|---|---|---|
Market Cap | $12.73B | $5.08B |
Volume | 40,961,424 | 685,276 |
Sector | Technology | Health |
52-Week High | $72.41 | $113.08 |
52-Week Low | $26.59 | $26.19 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $10.66B | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $34.73, down 4.25% today, with a bearish technical signal despite bullish oscillators. The company shows strong revenue growth (2025: $130M, 2026: $246M) but deep losses (2025: -$510M, 2026: -$1.4B), resulting in negative margins. Analyst consensus is bullish with a $65.20 price target (66.7% Buy ratings), supported by recent positive coverage from Bank of America and media optimism around quantum computing prospects.
Outlook: High growth potential in quantum computing with institutional backing, but profitability remains distant. Risks include cash burn, execution challenges, and rich valuations (P/S: 43.6). Investors must weigh long-term disruption potential against near-term financial strain.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
